Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 for NF2-Related Vestibular Schwannoma
NCT01490476Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in neurofibromatosis type 2 (NF2), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2012; status: completed.
02
Drugs
everolimus
03
Conditions
neurofibromatosis type 2 (NF2)
Beyond the preview
Go deeper on NCT01490476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490476.